Ready to Jump After Recent Trade: Chromadex Corp (CDXC)

With 1.08 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.78 million shares. The 52-week range on CDXC shows that it touched its highest point at $9.18 and its lowest point at $1.57 during that stretch. It currently has a 1-year price target of $9.37. Beta for the stock currently stands at 2.20.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CDXC was up-trending over the past week, with a rise of 36.52%, but this was up by 35.33% over a month. Three-month performance surged to 1.18% while six-month performance rose 142.14%. The stock gained 345.09% in the past year, while it has gained 45.15% so far this year. A look at the trailing 12-month EPS for CDXC yields 0.11 with Next year EPS estimates of 0.18. For the next quarter, that number is 0.02. This implies an EPS growth rate of 6.06% for this year and 51.43% for next year.

Float and Shares Shorts:

At present, 77.33 million CDXC shares are outstanding with a float of 49.23 million shares on hand for trading.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CDXC since 1 analysts follow the stock currently. There are 1 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $0.06 being high and $0.02 being low. For CDXC, this leads to a yearly average estimate of $0.04. Based on analyst estimates, the high estimate for the next quarter is $0.03 and the low estimate is $0.01. The average estimate for the next quarter is thus $0.02.